bpc 157 dosing guidelines for humans bpc-157 protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved Gray market peptides blur drug
Description
It appears to be beneficial to most of the human organs without any side effect or toxicity
(His department oversees the FDA.) But FDA does take action occasionally
Credit: Kirkland Signature Pros Affordable, potent source of B12 USP-verified No synthetic dyes or artificial flavors Cons Very high dose may cause digestive upset Contains a small amount of sucralose Individuals who are severely deficient in B12 may be advised by their healthcare provider to opt for a higher, extra-strength dose of the nutrient
Schedule: Weekly subcutaneous injection on the same day each week for 1216+ weeks
Acidity Buffer
